Dr. Vasif Cuneyt Kalfa Sr., MD

Dr. Kalfa practices at Allergy and Asthma Clinic of East Lansing in East Lansing, Michigan.

Dr. Kalfa's NPI, 1376567735, was assigned on July 27, 2006. Dr. Kalfa holds Michigan license 4301080350.

Dr. Kalfa's primary practice is Allergy and Asthma Clinic of East Lansing, at 612 W Lake Lansing Rd, East Lansing, MI 48823 in Ingham County. The practice phone is (517) 324-7020.

Dr. Kalfa's primary practice is Allergy and Asthma Clinic of East Lansing in East Lansing, Michigan. Dr. Kalfa is also affiliated with University of Michigan Health-Sparrow Lansing. The medical group on file is Allergy & Asthma Clinic of East Lansing. Dmand AI also links Dr. Kalfa to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalfa practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Kalfa's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Kalfa's licenses on file in 2 states: Michigan and Maryland.

CMS data shows 8,391 Medicare services from Dr. Kalfa across 11 procedure codes in 2024, for 186 Medicare patients. Medicare paid $67,446 for them. Every service was in an office.

CMS counts 186 Medicare patients who saw Dr. Kalfa in 2024. The largest group is 65 to 74, with 77 patients. 62% of them have high blood pressure, and 61% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalfa's median patient age at 38, with 62% women.

In 2024, Dr. Kalfa wrote 2,203 Medicare Part D claims for 366 patients. 71% of them were for generic drugs. CMS names the drug for 2,009 of them, across 31 drugs with 11 or more claims each, at $795,520 in total drug cost. In 2023, CMS named 1,937 claims across 36 drugs.

Dr. Kalfa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 339 general payments to Dr. Kalfa from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,038.